Fig. 4.
Fig. 4. Changes in clonotype-positive T cells in H-2d→H-2dxb tumor-bearing chimeras. / Three months after BM reconstitution, H-2d→H-2dxb (A) or H-2b→ H-2dxb (B) chimeras received 1 × 106 anti-HA CD4+ TCR transgenic T cells IV. One day later, half the animals in each set of chimeras were challenged with 1 × 106 A20HA tumor cells given IV. On day +22 after tumor challenge, all the animals were killed, and purified splenic T cells were analyzed by 2-color flow cytometry staining for CD4 versus anti-HA TCR clonotype (MoAb 6.5). (C) Background staining was done using this antibody combination on spleen cells from BALB/c mice without transgenic T-cell transfer. Three mice were included per group. Shown are representative FACS plots from individual mice in each group. Upper right quadrant numbers: percentage of double-positive T cells.

Changes in clonotype-positive T cells in H-2d→H-2dxb tumor-bearing chimeras.

Three months after BM reconstitution, H-2d→H-2dxb (A) or H-2b→ H-2dxb (B) chimeras received 1 × 106 anti-HA CD4+ TCR transgenic T cells IV. One day later, half the animals in each set of chimeras were challenged with 1 × 106 A20HA tumor cells given IV. On day +22 after tumor challenge, all the animals were killed, and purified splenic T cells were analyzed by 2-color flow cytometry staining for CD4 versus anti-HA TCR clonotype (MoAb 6.5). (C) Background staining was done using this antibody combination on spleen cells from BALB/c mice without transgenic T-cell transfer. Three mice were included per group. Shown are representative FACS plots from individual mice in each group. Upper right quadrant numbers: percentage of double-positive T cells.

Close Modal

or Create an Account

Close Modal
Close Modal